Revenue: As of FY2025 Q4, the actual value is USD 258.35 M.

EPS: As of FY2025 Q4, the actual value is USD 0.45.

EBIT: As of FY2025 Q4, the actual value is USD 25.68 M.

Financial and Operational Metrics for NOVANTA INC.

Fourth Quarter 2025 Performance

• Net Income (GAAP): Novanta Inc. reported GAAP net income of $17.5 million for Q4 2025, an increase from $16.5 million in Q4 2024.
• Operating Income (GAAP): GAAP operating income was $24.8 million, down from $26.7 million in the prior year quarter.
• Adjusted Operating Income (Non-GAAP): Adjusted operating income increased to $48.3 million, up from $43.3 million in Q4 2024.
• Adjusted EBITDA (Non-GAAP): Adjusted EBITDA increased 17% to $60.7 million, compared to $52.1 million in Q4 2024.
• Gross Profit (GAAP): Gross profit was $113.263 million, up from $108.225 million in Q4 2024.
• Adjusted Gross Profit (Non-GAAP): Adjusted gross profit was $117.506 million, up from $111.913 million in Q4 2024.
• Operating Costs: Total operating expenses were $88.431 million, compared to $81.518 million in Q4 2024.
• Operating Cash Flow: Operating cash flow was $8.8 million, a significant decrease from $61.6 million in Q4 2024, primarily due to temporary increases in net working capital from regionalizing manufacturing.
• Free Cash Flow (Non-GAAP): Free cash flow was $5.192 million, down from $59.486 million in Q4 2024.

Full Year 2025 Performance

• Net Income (GAAP): GAAP net income was $53.8 million for the full year 2025, down from $64.1 million in 2024.
• Operating Income (GAAP): GAAP operating income was $94.0 million, a decrease from $110.6 million in 2024.
• Adjusted Operating Income (Non-GAAP): Adjusted operating income was $175.4 million, up from $171.5 million in 2024.
• Adjusted EBITDA (Non-GAAP): Adjusted EBITDA increased 5.3% to $221.0 million, compared to $209.8 million in 2024.
• Gross Profit (GAAP): Gross profit was $435.284 million, up from $421.545 million in 2024.
• Adjusted Gross Profit (Non-GAAP): Adjusted gross profit was $451.625 million, up from $441.588 million in 2024.
• Operating Costs: Total operating expenses were $341.272 million, compared to $310.961 million in 2024.
• Operating Cash Flow: Operating cash flow was $64.1 million, a decrease from $158.5 million in 2024, driven by temporary increases in net working capital from regionalized manufacturing initiatives.
• Free Cash Flow (Non-GAAP): Free cash flow was $54.025 million, down from $141.523 million in 2024.

Segment Revenue

• Automation Enabling Technologies: Revenue for Q4 2025 was $130.680 million, up from $127.798 million in Q4 2024. For the full year 2025, revenue was $500.835 million, up from $490.620 million in 2024.
• Medical Solutions: Revenue for Q4 2025 was $127.669 million, up from $110.262 million in Q4 2024. For the full year 2025, revenue was $479.765 million, up from $458.625 million in 2024.

Other Key Metrics

• Organic Revenue Growth (Non-GAAP): Increased by 2.2% in Q4 2025, but decreased by -0.5% for the full year 2025.
• Customer Bookings: Increased 25% in Q4 2025, with an overall book-to-bill ratio of 1.11x. For the full year 2025, customer bookings advanced 14%.
• Total Debt (GAAP) (as of Dec 31, 2025): Total debt was $250.829 million.
• Total Cash (as of Dec 31, 2025): Total cash was $380.871 million.
• Net Debt (Non-GAAP) (as of Dec 31, 2025): Net debt was -$121.316 million.

Outlook / Guidance for 2026

Novanta Inc. expects GAAP revenue for the full year 2026 to be in the range of $1,030 million to $1,050 million. Adjusted EBITDA is anticipated to be between $245 million and $250 million, with operating cash flow projected in the range of $145 million to $185 million. For the first quarter of 2026, GAAP revenue is projected to be $250 million to $255 million.